Literature DB >> 32278975

Risk Factors for Early Readmission After Acute Pancreatitis: Importance of Timely Interventions.

Siavash Bolourani1, Li Diao2, Dane A Thompson1, Ping Wang1, Gene F Coppa3, Vihas M Patel3, Matthew D Giangola4.   

Abstract

BACKGROUND: Despite improvements in the diagnosis and care of acute pancreatitis, the mortality, morbidity, and long-term complications of this disease currently account for an annual cost of $10 billion in the United States. Lack of high-quality consolidated clinical data about this ever-increasing national and global burden makes it challenging to be able to recognize at-risk populations and intervene to avoid early readmission (ER) (i.e., readmission within 30 d of hospital discharge or ER).
METHODS: We reviewed the National Readmission Database for 2016. We retrieved 25,476 ER out of a total of 188,757 patients admitted with acute pancreatitis (ICD-10 diagnosis of K85), alive at discharge. Patients younger than 18 at the time of initial admission were excluded. Diagnostic characteristics and procedures performed were extracted from ICD-10 data. Based on patient demographics and the diagnostic and procedural profiles from their initial admission, we identified clusters of risk factors for ER using agglomerative hierarchical clustering. These are depicted in a correlation matrix.
RESULTS: Acute pancreatitis is associated with a 13.5% overall ER rate. Certain pre-existing chronic diseases, particularly cardiovascular disease diagnoses and interventions at initial presentation increase the odds of ER. In contrast to interventions on the pancreas, interventions on the biliary system correlated with lower odds of ER. Furthermore, the earlier the biliary system intervention was performed during the initial hospitalization, the lower the odds of ER. We identified five clusters of interrelationships: age/comorbidity cluster, cirrhosis cluster, sepsis/pulmonary complication cluster, biliary intervention cluster, and high-risk of mortality cluster.
CONCLUSIONS: We identified several potentially modifiable risk factors for ER of patients hospitalized with acute pancreatitis, which included timing of biliary interventions. Furthermore, we identified clusters of interrelationships that further illuminate which complications tend to occur concomitantly and ultimately contribute to ER. By identifying risk factors and elucidating their interactions, we have improved our understanding of this highly morbid disease and offer potential points of intervention to reduce ER.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute pancreatitis; Cholecystectomy; ERCP; Necrosectomy; Pancreatic drainage; Readmission

Mesh:

Year:  2020        PMID: 32278975     DOI: 10.1016/j.jss.2020.03.003

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  4 in total

Review 1.  Cannabinoid-Related Acute Pancreatitis: An Update from International Literature and Individual Case Safety Reports.

Authors:  Camille Azam; Louis Buscail; Adrian Culetto; Maryse Lapeyre-Mestre
Journal:  Drug Saf       Date:  2022-02-18       Impact factor: 5.606

Review 2.  Antioxidant Therapy in Pancreatitis.

Authors:  Lourdes Swentek; Dean Chung; Hirohito Ichii
Journal:  Antioxidants (Basel)       Date:  2021-04-23

3.  Immune Dysfunction is Associated with Readmission in Survivors of Sepsis Following Infected Pancreatic Necrosis.

Authors:  Jiangtao Yin; Wenjian Mao; Xiaojia Xiao; Xianqiang Yu; Baiqiang Li; Faxi Chen; Jiajia Lin; Jing Zhou; Jing Zhou; Zhihui Tong; Lu Ke; Weiqin Li
Journal:  J Inflamm Res       Date:  2021-10-20

4.  Clinical Outcomes and Predictors of Thirty-Day Readmissions of Hypertriglyceridemia-Induced Acute Pancreatitis.

Authors:  Asim Kichloo; Zain El-Amir; Maria Aucar; Dushyant Singh Dahiya; Mohammad Al-Haddad; Sailaja Pisipati; Hassan Beiz; Gurdeep Singh; Darshan Gandhi; Jagmeet Singh; Patrick Pathappillil; Haseeb Mohideen; Hafeez Shaka
Journal:  Gastroenterology Res       Date:  2022-01-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.